Insys Therapeutics Inc (INSYQ)

OTC Markets
0.04
0.00(0.00%)
  • Volume:
    0
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    0.04 - 0.05

INSYQ Overview

Prev. Close
0.05
Day's Range
0.04-0.05
Revenue
-
Open
0.04
52 wk Range
0-0
EPS
-3.07
Volume
0
Market Cap
3.19M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
1,645,617
P/E Ratio
-
Beta
2.12
1-Year Change
-20%
Shares Outstanding
75,920,000
Next Earnings Date
-
What is your sentiment on Insys Therapeutics Inc?
or
Market is currently closed. Voting is open during market hours.

Insys Therapeutics Inc News

Insys Therapeutics Inc Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving Averages
Technical Indicators
Summary

Insys Therapeutics Inc Company Profile

Insys Therapeutics Inc Company Profile

Employees
226

On February 18, 2020, INSYS Therapeutics, Inc. went out of business as per its Chapter 11 liquidation filing under bankruptcy. Insys Therapeutics, Inc., a specialty pharmaceutical company, focuses on cannabinoids and drug delivery systems that address unmet patient needs. The company markets SUBSYS, a sublingual fentanyl spray for breakthrough cancer pain in opioid-tolerant adult patients; and SYNDROS, an orally administered liquid formulation of dronabinol for the treatment of chemotherapy-induced nausea and vomiting, and anorexia associated with weight loss in patients with AIDS. It also develops Cannabidiol Oral Solution, a synthetic cannabidiol, for the treatment of rare childhood epilepsy syndromes that include west syndrome and childhood absence epilepsy, as well as glioblastoma multiforme, pontine glioma, and pediatric schizophrenia. In addition, the company develops Buprenorphine Sublingual Spray for acute pain; Epinephrine Nasal Spray for allergic reactions, including anaphylaxis; and Naloxone Nasal Spray for opioid antagonist. Insys Therapeutics, Inc. is headquartered in Chandler, Arizona.

Read More
  • Is this company going to be listed again or has it completely disappeared?
    0
    • Is this company going to be listed again or has it completely disappeared?
      0
      • is it still safe to buy insys stock? it keeps going up?
        1
        • any thoughts on INSYQ
          1
          • i think delisted soon
            0
            • After hour -12.40%... time to jump in?
              0
              • https://stocktwits.com/Sennacherib/message/167759761
                0
                • https://stocktwits.com/Sennacherib/message/167760672 #insys not delisted. They have confirm for buyout within 90 days
                  0
                  • Wont be long till it delists
                    0
                    • Why is it not moving
                      0
                  • xd
                    0
                    • any chance it will go or no
                      0
                      • Such a swing stock. Up and down 4-10 % each day almost..Great to trade.
                        0
                        • When would be a good time to sell or should I just keep on riding the wave.
                          0
                          • With marijuana legal in Cali, Colorado, dc, new England, and rumor has it NJ by 2018? Ride the wave my friend
                            0
                          • i got in at 10.67 .
                            0
                          • Buy at 3.6?
                            1
                        Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                        Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.